Carasent acquires Medrave Software

Carasent ASA has acquired Medrave Software AB. Medrave is a Scandinavian market leader in quality improvement software for healthcare practices within primary care and secondary outpatient care.

Medrave’s module-based software provides clinical reports to health care practices. The quality improvement solution automatically collects and sorts data, analyze and visualize, tracks and benchmarks KPIs, and provides automatic reporting. Medrave has a customer base of more than 260 clients across Sweden and Norway, covering 1,646 practices and an estimated 8.8 million patients.

Carasent ASA focuses on developing companies and e-health services in the Scandinavian market. The company is listed on the Oslo Stock Exchange.

Mannheimer Swartling advised Carasent ASA on legal matters in the transaction.


This website uses cookies to perform certain functions and help you navigate the site efficiently. A cookie is a text file with a small amount of information that is stored on your device. We share some of the information we obtain through these cookies with third parties. We only use cookies that are necessary for the site to function correctly and they therefore cannot be turned off. For further information, see Information on the use of cookies.